Navigation Links
Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
Date:11/4/2008

HAE: TSX

MONTREAL, Nov. 4 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE) announced today that Joseph Galli, Chairman and Chief Executive Officer of Haemacure, will present at the Rodman and Renshaw Annual Global Investor Conference being held November 10-12 in New York. Mr. Galli will present a corporate progress report, including an update on the Company's lead product candidate, Hemaseel(R)HMN (fibrin sealant). The Haemacure presentation is scheduled to begin at 3:15 p.m. local time on Monday, November 10th.

The Haemacure presentation will be webcast live and may be accessed by clicking on the following link: http://www.wsw.com/webcast/rrshq14/hae.cn. The presentation will also be available on the Haemacure website, http://www.haemacure.com, for a limited time following the conference.

Additional information on the Rodman and Renshaw Annual Global Investor Conference is available at http://www.rodmanandrenshaw.com/conferences.

Please visit the site at least five minutes prior to start time for instructions.

About Haemacure

Haemacure Corporation is a specialty biotherapeutics company developing high-value human plasma-derived protein products for commercialization. Haemacure's research and development effort is driven by its proprietary plasma protein extraction technology to develop next-generation products, including surgical hemostats. Haemacure's lead product candidate, Hemaseel(R)HMN, is a fibrin sealant to enter pivotal Phase II/Phase III clinical trials during the first half of 2009. Haemacure's second product candidate is thrombin, a component of its fibrin sealant, now in preclinical stage. Follow-on development will focus on the use of its fibrin sealant in adhesion prevention, aesthetics, combination with
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
3. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
4. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
5. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
6. Haemacure Reports on its annual general and special meeting of shareholders
7. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
8. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
9. Haemacure financing receives shareholder consent - Series B Warrants are amended
10. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... ... announces that CEREC technology is now available at CitiDent. CEREC is a newer ... In addition to saving time for patients by eliminating the need for multiple ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is proud to announce ... Doximity. Faculty, residents and staff are honored to have contributed to the success ... our ophthalmology residency program. Our faculty places a high priority on our educational programs ...
(Date:9/4/2015)... ... 2015 , ... Steven Winter Associates, Inc., (SWA) is pleased ... for the Residential Award of Merit by the Connecticut Green Building Council (CTGBC) ... highly competitive field of submissions, the net-zero energy residence will be honored at ...
(Date:9/4/2015)... ... September 04, 2015 , ... Friday night, Chicago lovebirds Jenny McCarthy and ... Night of Hope event supporting families affected by autism, raising nearly $250,000. , ... joined together at the Oscar Swan Inn to support the cause. , McCarthy ...
(Date:9/3/2015)... IL (PRWEB) , ... September 03, 2015 , ... ... Diagnostics Inc. , a privately held medical technology company that will bring low-cost ... select markets worldwide. , Preora’s proprietary and automated technology platform detects and ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3
... explanations that can be offered, one that doesn’t come readily ... that myelin, the sheet of fat that coats a neuron’s ... impulses — is akin to the wrapping around an electrical ... UCLA neurology professor George Bartzokis, M.D., has already shown that ...
... in Himachal Pradesh have removed an 18 kg ovarian tumour ... at a hospital in Kullu, 240 km from here, media ... had reported at the hospital with pain and a swelling ... remove the hard oval shaped tumour from the right side ...
... recently has concluded that monitoring fetal oxygen when a woman ... may be more healthier or decrease the chances of an ... monitoring, during labor, it has been a routine practice in ... unborn fetus .This is done in the current view held ...
... of there superficial similarity in structure and function. Its ... recent study done by international researchers have tapped into ... are, in reality. The new studies will help to ... genetics. ,Scientists claim that DNA can vary ...
... More than ever, children and adolescents are enjoying ... organized sport. Yet many observers have noted problems ... medicine physicians have seen alarming increases in sport-related ... the Clinical Journal of Sport Medicine is a ...
... has indicated the benefits of the lupin plant//, whose ... in reduced calorie intake. The researchers have found that ... in controlling appetite. Lupin is a serious contender with ... ,The investigators conducted a study with 16 subjects who ...
Cached Medicine News:Health News:Blame Myelin for Many Neuropsychiatric Disorders 2Health News:Fetal Oxygen Monitors Not Helpful To Prevent Mishaps In Labor:Says Study 2Health News:Humans are not 'peas in a pod' says a study 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 3
(Date:9/4/2015)... , Sept. 4, 2015  Essilor is pleased to ... greatest defense against the eyestrain that comes with the ... to serve as an everyday pair of glasses to ... who are on smart phones, tablets and computers for ... those who require a prescription but also those who ...
(Date:9/4/2015)... PUNE, India , September 4, 2015 ... "Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and ... by Technology and by Product - Global Forecast to ... expected to reach USD 2.5 Billion by 2020, growing ... from 2015 to 2020. Browse 139 ...
(Date:9/4/2015)... Sept. 4, 2015  Allergan plc (NYSE: AGN ) ... Saunders , CEO and President of Allergan, will provide an ... Stanley Global Healthcare Conference 2015 in New York, ... The presentation will take place on Thursday, ... Grand Hyatt New York, 109 East 42nd Street, ...
Breaking Medicine Technology:Essilor Launches New Eyezen Glasses Specifically Designed For A Digital Focused Audience 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3
... College of Emergency Physicians, a national sponsor of the ... safe disposal of expired, unused and unwanted medications in ... accidental overdose.  A recent study reports that prescription drugs ... 2008, more than half of the total 36,450 overdose ...
... The U.S. Food and Drug Administration today approved the ... heart valve damaged by senile aortic valve stenosis without ... Senile aortic valve stenosis is a progressive, age-related disease ... cause the valve to narrow. As the heart works ...
Cached Medicine Technology:Emergency Physicians Tell the Public,''Get Rid of Your Stash'' of Unwanted Meds on November 12th 2FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery 2FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery 3
100L...
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
This fixed-volume digital micropipet is used to accurately measure and transfer 20 microliters of solution....
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: